<?xml version="1.0" encoding="utf-8"?>
<root>
  <passage>
    <infon key="section_type">TITLE</infon>
    <text>Low prevalence of liver-kidney microsomal autoantibodies of type 1 (LKM1) in hepatitis C seropositive subjects on Crete, Greece</text>
  </passage>
  <passage>
    <infon key="section_type">ABSTRACT</infon>
    <text>Autoantibodies, particularly ANA and ASMA, are prevalent in patients with HCV seropositive Crete, while LKM1 autoantibody is uncommon.</text>
  </passage>
  <passage>
    <infon key="section_type">INTRO</infon>
    <text>Human papillomaviruses (HPV) are thought to initiate and cause endogenous genetic changes in the progression of cervical cancer, which is a common malignancy among women worldwide, particularly in developing countries. Epidemiological studies have shown that most human CCs carry the &quot;high risk&quot; HPV types 16, 18, 31 and 33. In addition to E6, E7 and other HPV proteins that interact with human tumor suppresser gene products, the integration of these proteins results in the linearization of HPR DNA between E1 and L1 genes, which in turn disrupts the viral E2 gene and leads to the expression of E6 and E7% genes. The genomic rearrangement is believed to be essential for the transformation and proliferation of the early precursors to these cancers. From a diagnostic perspective, the viral DNA found in CC can be used as recombinant genetic markers. For instance, cervical pre-malignant lesions can serve as an example. More reassortment lines have revealed that there is some tumor DNA in the blood of patients who have undergone medical procedures. This DNA can be detected in plasma or serum by means of specific genetic and epigenetic alterations of the primary tumor. Although the mechanism of this action is unknown, the presence of tumorDNA in blood may provide useful information for diagnostics and prognostic purposes. Viral DNA has been found to be present in the circulatory system of patients with primary tumors resulting from viral infection, as evidenced by the prevalence of hepatitis viral genomes and Epstein-Barr viral (EBV) DNA in patients diagnosed with nasopharyngeal cancer. Furthermore, EBV DNA can serve as a valuable monitoring tool for patients. As HPV DNA is classified as an immunoglobulin (CC) marker, we examined whether it was present in the plasma of CC patients and whether its origin was directly from tumor cells. Additionally, our study demonstrated whether the circulating HPI DNA has any diagnostic and prognostic utility for those with CF or normal blood type.</text>
  </passage>
  <passage>
    <infon key="section_type">CONCL</infon>
    <text>Cisapride reduces the risk of gastric contents being aspirated in patients who are semirecumbent and intubated, according to our research. Cisapride's ability to prevent gastric content aspiration is not fully matched by traditional protective measures such as semirecumbent position and regular checking of cuff leaking. Further studies are needed to determine whether this drug truly prevents ventilator-associated pneumonia, bronchitis, or pulmonary constriction.</text>
  </passage>
</root>
